A general practice trial of an amoxycillin/flucloxacillin combination (Suprapen) in proven bacterial infections.
Ninety-three cases of proven bacterial infection occurring in general practice were treated with an amoxycillin/flucloxacillin combination. There was a satisfactory clinical response in 98% of patients and an overall bacteriological success rate of 95.7%. Eleven patients (9.1%) complained of side-effects but withdrawal of the combination was necessary in only one patient who developed a rash.
D000328:Adult; D000658:Amoxicillin / Q000008:administration & dosage* / Q000009:adverse effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D003023:Cloxacillin / Q000031:analogs & derivatives*; D004338:Drug Combinations; D005436:Floxacillin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007223:Infant; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
D004338:Drug Combinations; D005436:Floxacillin; D000658:Amoxicillin; D003023:Cloxacillin